Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

John R. Mascola, Gabriela Stiegler, Thomas C. VanCott, Hermann Katinger, Calvin B. Carpenter, Chris E. Hanson, Holly Beary, Deborah Hayes, Sarah S. Frankel, Deborah L. Birx, Mark G. Lewis, Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies Nature Medicine. ,vol. 6, pp. 207- 210 ,(2000) , 10.1038/72318

Preston A. Marx, Alexander I. Spira, Agegnehu Gettie, Peter J. Dailey, Ronald S. Veazey, Andrew A. Lackner, C. James Mahoney, Christopher J. Miller, Lee E. Claypool, David D. Ho, Nancy J. Alexander, Progesterone implants enhance SIV vaginal transmission and early virus load Nature Medicine. ,vol. 2, pp. 1084- 1089 ,(1996) , 10.1038/NM1096-1084

Leonidas Stamatatos, Lynn Morris, Dennis R Burton, John R Mascola, Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nature Medicine. ,vol. 15, pp. 866- 870 ,(2009) , 10.1038/NM.1949

A. Nichole Cline, Julian W. Bess, Michael Jr Piatak, Jeffrey D. Lifson, Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. Journal of Medical Primatology. ,vol. 34, pp. 303- 312 ,(2005) , 10.1111/J.1600-0684.2005.00128.X

Ann J. Hessell, Eva G. Rakasz, Pascal Poignard, Lars Hangartner, Gary Landucci, Donald N. Forthal, Wayne C. Koff, David I. Watkins, Dennis R. Burton, Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers PLOS Pathogens. ,vol. 5, ,(2009) , 10.1371/JOURNAL.PPAT.1000433

Ronald Willey, Martha C. Nason, Yoshiaki Nishimura, Dean A. Follmann, Malcolm A. Martin, Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay. AIDS Research and Human Retroviruses. ,vol. 26, pp. 89- 98 ,(2010) , 10.1089/AID.2009.0144

Y. Nishimura, T. Igarashi, N. L. Haigwood, R. Sadjadpour, O. K. Donau, C. Buckler, R. J. Plishka, A. Buckler-White, M. A. Martin, Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 15131- 15136 ,(2003) , 10.1073/PNAS.2436476100

David C Montefiori, John R Mascola, Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? Current Opinion in Hiv and Aids. ,vol. 4, pp. 347- 351 ,(2009) , 10.1097/COH.0B013E32832F4A4D

D. R. Burton, P. Poignard, R. L. Stanfield, I. A. Wilson, Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses Science. ,vol. 337, pp. 183- 186 ,(2012) , 10.1126/SCIENCE.1225416

Johannes F. Scheid, Hugo Mouquet, Niklas Feldhahn, Michael S. Seaman, Klara Velinzon, John Pietzsch, Rene G. Ott, Robert M. Anthony, Henry Zebroski, Arlene Hurley, Adhuna Phogat, Bimal Chakrabarti, Yuxing Li, Mark Connors, Florencia Pereyra, Bruce D. Walker, Hedda Wardemann, David Ho, Richard T. Wyatt, John R. Mascola, Jeffrey V. Ravetch, Michel C. Nussenzweig, Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals Nature. ,vol. 458, pp. 636- 640 ,(2009) , 10.1038/NATURE07930